Patents by Inventor Robert Lemanske

Robert Lemanske has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic predictor of efficacy of anti-asthmatic agents for improving pulmonary function
    Publication number: 20060069074
    Abstract: The present invention relates to methods for determining and predicting the efficacy of therapeutics for the treatment of an individual with asthma based on that individual's ?2-adrenergic receptor. The invention finds particular applicability to the treatment of an individual with asthma with an inhaled corticosteroid or a leukotriene receptor antagonist who is homozygous for arginine at position 16 of the ?2-adrenergic receptor.
    Type: Application
    Filed: July 7, 2005
    Publication date: March 30, 2006
    Inventors: Robert Lemanske, Christine Sorkness, Vernon Chinchilli, Wenlei Liu, Brenda Phillips, Robert Zeiger, Gregory Heldt, Fernando Martinez, Walter Klimecki, Theresa Guilbert, Wayne Morgan, Stanley Szefler, Gary Larsen, Lynn Taussig, Joseph Spahn, Robert Strunk, Leonard Bacharier, Gordon Bloomberg
  • Diagnosing asthma patients predisposed to adverse beta-agonist reactions
    Publication number: 20020119474
    Abstract: The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of &bgr;-agonists. The invention also provides kits useful for this purpose.
    Type: Application
    Filed: November 21, 2001
    Publication date: August 29, 2002
    Inventors: Jeffrey M. Drazen, Vern Chinchilli, Richard Martin, Robert Lemanske, Jean G. Ford, James E. Fish, Homer Boushey
  • Diagnosing asthma patients predisposed to adverse .beta.-agonist reactions
    Patent number: 6156503
    Abstract: The present invention provides a novel method for identifying individuals who are likely to have negative responses to regular administration of .beta.-agonists. The invention also provides kits useful for this purpose.
    Type: Grant
    Filed: March 3, 1997
    Date of Patent: December 5, 2000
    Assignees: The Regents of the University of California, The Trustees of Columbia University in the City of New York, The Penn State Research Foundation, National Jewish Medical and Research Center, Wisconsin Alumni Research Center, Thomas Jefferson University, Brigham and Women's Hospital
    Inventors: Jeffrey M. Drazen, Vern Chinchilli, Richard Martin, Robert Lemanske, Jean G. Ford, James E. Fish, Homer Boushey